TY - JOUR
T1 - Mechanical dyssynchrony after cardiac resynchronization therapy for severely symptomatic heart failure is associated with risk for ventricular arrhythmias
AU - Haugaa, Kristina H.
AU - Marek, Josef J.
AU - Ahmed, Mohammed
AU - Ryo, Keiko
AU - Adelstein, Evan C.
AU - Schwartzman, David
AU - Saba, Samir
AU - Gorcsan, John
N1 - Funding Information:
Dr Adelstein receives research grant support from Medtronic (Minneapolis, MN) and St. Jude Medical (St. Paul, MN). Dr. Schwartzman receives research grant support from Medtronic and Boston Scientific Corporation (Natick, MA). Dr. Saba receives research grant support from Medtronic and Boston Scientific Corporation. Dr. Gorcsan receives research grant support from Biotronik (Berlin, Germany), GE Healthcare (Milwaukee, WI), Toshiba (Tokyo, Japan), Medtronic, and St. Jude Medical. Dr. Haugaa was funded by the South-Eastern Norway Regional Health Authority .
PY - 2014/8
Y1 - 2014/8
N2 - Background Risk factors for ventricular arrhythmias after cardiac resynchronization defibrillator therapy (CRT-D) for severely symptomatic heart failure are of clinical importance but are not clearly defined. The objective of this study was to test the hypothesis that mechanical dyssynchrony after CRT-D is a risk factor for ventricular arrhythmias. Methods A total of 266 consecutive CRT-D patients with class III or IV heart failure, QRS duration ≥120 msec, and ejection fractions ≤ 35% were prospectively studied. Dyssynchrony was assessed before and 6 months after CRT-D using speckle-tracking radial strain anteroseptal-to-posterior wall delay, predefined as ≥130 msec. Ventricular arrhythmias were predefined as appropriate antitachycardia pacing or shock, and the combined end point of ventricular arrhythmias, death, transplantation, or left ventricular assist device implantation was followed over 2 years. Results Of the initial 266 patients, 11 died, five underwent transplantation, three received left ventricular assist devices before their 6-month echocardiographic examinations, 19 (7%) had inadequate speckle-tracking at 6-month follow-up, and 27 (10%) were lost to follow-up. Accordingly, the study group consisted of 201 patients. Dyssynchrony after CRT-D was observed in 79 (39%) and was associated with a significantly higher ventricular arrhythmic event rate: 21% (P <.001) with persistent dyssynchrony and 35% (P <.001) with new dyssynchrony, compared with 8% with no dyssynchrony after CRT-D. The combined end point of ventricular arrhythmias, death, transplantation, or left ventricular assist device implantation was significantly associated with dyssynchrony after CRT-D (hazard ratio, 2.53; 95% confidence interval, 1.49-4.28; P =.001). Dyssynchrony after CRT-D was associated with ventricular arrhythmias or death in patient subgroups by cardiomyopathy type, QRS width, and morphology (P <.05 for all). Conclusions Persistent or new radial dyssynchrony after CRT-D in severely symptomatic patients with heart failure with widened QRS complexes and reduced ejection fractions was associated with an increased rate of ventricular arrhythmias or death and appears to be a marker for a less favorable prognosis.
AB - Background Risk factors for ventricular arrhythmias after cardiac resynchronization defibrillator therapy (CRT-D) for severely symptomatic heart failure are of clinical importance but are not clearly defined. The objective of this study was to test the hypothesis that mechanical dyssynchrony after CRT-D is a risk factor for ventricular arrhythmias. Methods A total of 266 consecutive CRT-D patients with class III or IV heart failure, QRS duration ≥120 msec, and ejection fractions ≤ 35% were prospectively studied. Dyssynchrony was assessed before and 6 months after CRT-D using speckle-tracking radial strain anteroseptal-to-posterior wall delay, predefined as ≥130 msec. Ventricular arrhythmias were predefined as appropriate antitachycardia pacing or shock, and the combined end point of ventricular arrhythmias, death, transplantation, or left ventricular assist device implantation was followed over 2 years. Results Of the initial 266 patients, 11 died, five underwent transplantation, three received left ventricular assist devices before their 6-month echocardiographic examinations, 19 (7%) had inadequate speckle-tracking at 6-month follow-up, and 27 (10%) were lost to follow-up. Accordingly, the study group consisted of 201 patients. Dyssynchrony after CRT-D was observed in 79 (39%) and was associated with a significantly higher ventricular arrhythmic event rate: 21% (P <.001) with persistent dyssynchrony and 35% (P <.001) with new dyssynchrony, compared with 8% with no dyssynchrony after CRT-D. The combined end point of ventricular arrhythmias, death, transplantation, or left ventricular assist device implantation was significantly associated with dyssynchrony after CRT-D (hazard ratio, 2.53; 95% confidence interval, 1.49-4.28; P =.001). Dyssynchrony after CRT-D was associated with ventricular arrhythmias or death in patient subgroups by cardiomyopathy type, QRS width, and morphology (P <.05 for all). Conclusions Persistent or new radial dyssynchrony after CRT-D in severely symptomatic patients with heart failure with widened QRS complexes and reduced ejection fractions was associated with an increased rate of ventricular arrhythmias or death and appears to be a marker for a less favorable prognosis.
UR - http://www.scopus.com/inward/record.url?scp=84905271226&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84905271226&partnerID=8YFLogxK
U2 - 10.1016/j.echo.2014.04.001
DO - 10.1016/j.echo.2014.04.001
M3 - Article
C2 - 24798865
AN - SCOPUS:84905271226
SN - 0894-7317
VL - 27
SP - 872
EP - 879
JO - Journal of the American Society of Echocardiography
JF - Journal of the American Society of Echocardiography
IS - 8
ER -